Cytogenetic  ||| S:0 E:12 ||| NNP
and  ||| S:12 E:16 ||| CC
clinical  ||| S:16 E:25 ||| JJ
analysis  ||| S:25 E:34 ||| NN
of  ||| S:34 E:37 ||| IN
340  ||| S:37 E:41 ||| CD
Chinese  ||| S:41 E:49 ||| JJ
patients  ||| S:49 E:58 ||| NNS
with  ||| S:58 E:63 ||| IN
primary  ||| S:63 E:71 ||| JJ
amenorrhea  ||| S:71 E:82 ||| NN
To  ||| S:82 E:85 ||| TO
analyze  ||| S:85 E:93 ||| VB
the  ||| S:93 E:97 ||| DT
relationship  ||| S:97 E:110 ||| NN
between  ||| S:110 E:118 ||| IN
karyotypes  ||| S:118 E:129 ||| NN
and  ||| S:129 E:133 ||| CC
clinic  ||| S:133 E:140 ||| NN
features  ||| S:140 E:149 ||| NNS
of  ||| S:149 E:152 ||| IN
patients  ||| S:152 E:161 ||| NNS
with  ||| S:161 E:166 ||| IN
primary  ||| S:166 E:174 ||| JJ
amenorrhea ||| S:174 E:184 ||| NN
.  ||| S:184 E:186 ||| .
G  ||| S:186 E:188 ||| NNP
banding  ||| S:188 E:196 ||| NN
was  ||| S:196 E:200 ||| VBD
done  ||| S:200 E:205 ||| VBN
for  ||| S:205 E:209 ||| IN
340  ||| S:209 E:213 ||| CD
patients  ||| S:213 E:222 ||| NNS
with  ||| S:222 E:227 ||| IN
primary  ||| S:227 E:235 ||| JJ
amenorrhea  ||| S:235 E:246 ||| NN
to  ||| S:246 E:249 ||| TO
facilitate  ||| S:249 E:260 ||| VB
individual  ||| S:260 E:271 ||| JJ
chromosome  ||| S:271 E:282 ||| NN
identification ||| S:282 E:296 ||| NN
,  ||| S:296 E:298 ||| ,
and  ||| S:298 E:302 ||| CC
if  ||| S:302 E:305 ||| IN
specific  ||| S:305 E:314 ||| JJ
staining  ||| S:314 E:323 ||| NN
for  ||| S:323 E:327 ||| IN
certain  ||| S:327 E:335 ||| JJ
portions  ||| S:335 E:344 ||| NNS
of  ||| S:344 E:347 ||| IN
the  ||| S:347 E:351 ||| DT
chromosome  ||| S:351 E:362 ||| NN
was  ||| S:362 E:366 ||| VBD
necessary ||| S:366 E:375 ||| JJ
,  ||| S:375 E:377 ||| ,
C  ||| S:377 E:379 ||| NNP
banding  ||| S:379 E:387 ||| NN
was  ||| S:387 E:391 ||| VBD
used ||| S:391 E:395 ||| VBN
.  ||| S:395 E:397 ||| .
The  ||| S:397 E:401 ||| DT
clinical  ||| S:401 E:410 ||| JJ
data  ||| S:410 E:415 ||| NNS
were  ||| S:415 E:420 ||| VBD
recorded  ||| S:420 E:429 ||| VBN
by  ||| S:429 E:432 ||| IN
physical  ||| S:432 E:441 ||| JJ
examination  ||| S:441 E:453 ||| NN
and  ||| S:453 E:457 ||| CC
ultrasound  ||| S:457 E:468 ||| JJ
scanning ||| S:468 E:476 ||| NN
.  ||| S:476 E:478 ||| .
Karyotype  ||| S:478 E:488 ||| JJ
analysis  ||| S:488 E:497 ||| NN
of  ||| S:497 E:500 ||| IN
the  ||| S:500 E:504 ||| DT
340  ||| S:504 E:508 ||| CD
patients  ||| S:508 E:517 ||| NNS
revealed  ||| S:517 E:526 ||| VBD
that  ||| S:526 E:531 ||| IN
180  ||| S:531 E:535 ||| CD
( ||| S:535 E:536 ||| -LRB-
52.94 ||| S:536 E:541 ||| NNP
% ||| S:541 E:542 ||| NN
)  ||| S:542 E:544 ||| -RRB-
patients  ||| S:544 E:553 ||| NNS
had  ||| S:553 E:557 ||| VBD
normal  ||| S:557 E:564 ||| JJ
female  ||| S:564 E:571 ||| JJ
karyotypes  ||| S:571 E:582 ||| NN
and  ||| S:582 E:586 ||| CC
160  ||| S:586 E:590 ||| CD
( ||| S:590 E:591 ||| -LRB-
47.06 ||| S:591 E:596 ||| NNP
% ||| S:596 E:597 ||| NN
)  ||| S:597 E:599 ||| -RRB-
patients  ||| S:599 E:608 ||| NNS
had  ||| S:608 E:612 ||| VBD
abnormal  ||| S:612 E:621 ||| JJ
karyotypes ||| S:621 E:631 ||| NN
.  ||| S:631 E:633 ||| .
The  ||| S:633 E:637 ||| DT
abnormal  ||| S:637 E:646 ||| JJ
karyotypes  ||| S:646 E:657 ||| NN
included  ||| S:657 E:666 ||| VBD
abnormal  ||| S:666 E:675 ||| JJ
X  ||| S:675 E:677 ||| NN
chromosome  ||| S:677 E:688 ||| NN
( ||| S:688 E:689 ||| -LRB-
150  ||| S:689 E:693 ||| CD
patients ||| S:693 E:701 ||| NNS
) ||| S:701 E:702 ||| -RRB-
,  ||| S:702 E:704 ||| ,
mosaic  ||| S:704 E:711 ||| JJ
X-Y  ||| S:711 E:715 ||| JJ
chromosome  ||| S:715 E:726 ||| NN
( ||| S:726 E:727 ||| -LRB-
4  ||| S:727 E:729 ||| CD
patients ||| S:729 E:737 ||| NNS
) ||| S:737 E:738 ||| -RRB-
,  ||| S:738 E:740 ||| ,
abnormal  ||| S:740 E:749 ||| JJ
autosome  ||| S:749 E:758 ||| NNS
( ||| S:758 E:759 ||| -LRB-
5  ||| S:759 E:761 ||| CD
patients ||| S:761 E:769 ||| NNS
) ||| S:769 E:770 ||| -RRB-
,  ||| S:770 E:772 ||| ,
and  ||| S:772 E:776 ||| CC
X-autosome  ||| S:776 E:787 ||| JJ
translocation  ||| S:787 E:801 ||| NNS
( ||| S:801 E:802 ||| -LRB-
1  ||| S:802 E:804 ||| CD
patient ||| S:804 E:811 ||| NN
) ||| S:811 E:812 ||| -RRB-
.  ||| S:812 E:814 ||| .
The  ||| S:814 E:818 ||| DT
main  ||| S:818 E:823 ||| JJ
clinical  ||| S:823 E:832 ||| JJ
manifestations  ||| S:832 E:847 ||| NNS
in  ||| S:847 E:850 ||| IN
patients  ||| S:850 E:859 ||| NNS
with  ||| S:859 E:864 ||| IN
primary  ||| S:864 E:872 ||| JJ
amenorrhea  ||| S:872 E:883 ||| NN
were  ||| S:883 E:888 ||| VBD
primordial  ||| S:888 E:899 ||| JJ
or  ||| S:899 E:902 ||| CC
absent  ||| S:902 E:909 ||| JJ
uterus  ||| S:909 E:916 ||| NNS
( ||| S:916 E:917 ||| -LRB-
95.9 ||| S:917 E:921 ||| CD
% ||| S:921 E:922 ||| NN
) ||| S:922 E:923 ||| -RRB-
,  ||| S:923 E:925 ||| ,
invisible  ||| S:925 E:935 ||| JJ
secondary  ||| S:935 E:945 ||| JJ
sex  ||| S:945 E:949 ||| NN
features  ||| S:949 E:958 ||| NNS
( ||| S:958 E:959 ||| -LRB-
68.8 ||| S:959 E:963 ||| CD
% ||| S:963 E:964 ||| NN
) ||| S:964 E:965 ||| -RRB-
,  ||| S:965 E:967 ||| ,
little  ||| S:967 E:974 ||| JJ
or  ||| S:974 E:977 ||| CC
absent  ||| S:977 E:984 ||| JJ
ovary  ||| S:984 E:990 ||| NNS
( ||| S:990 E:991 ||| -LRB-
62.6 ||| S:991 E:995 ||| CD
% ||| S:995 E:996 ||| NN
) ||| S:996 E:997 ||| -RRB-
,  ||| S:997 E:999 ||| ,
and  ||| S:999 E:1003 ||| CC
short  ||| S:1003 E:1009 ||| JJ
stature  ||| S:1009 E:1017 ||| NN
( ||| S:1017 E:1018 ||| -LRB-
30.0 ||| S:1018 E:1022 ||| NNP
% ||| S:1022 E:1023 ||| NN
) ||| S:1023 E:1024 ||| -RRB-
.  ||| S:1024 E:1026 ||| .
The  ||| S:1026 E:1030 ||| DT
incidence  ||| S:1030 E:1040 ||| NN
of  ||| S:1040 E:1043 ||| IN
short  ||| S:1043 E:1049 ||| JJ
stature  ||| S:1049 E:1057 ||| NN
in  ||| S:1057 E:1060 ||| IN
patients  ||| S:1060 E:1069 ||| NNS
with  ||| S:1069 E:1074 ||| IN
X  ||| S:1074 E:1076 ||| NNP
chromosome  ||| S:1076 E:1087 ||| NN
aberration  ||| S:1087 E:1098 ||| NNS
( ||| S:1098 E:1099 ||| -LRB-
46 ||| S:1099 E:1101 ||| CD
% ||| S:1101 E:1102 ||| NN
,  ||| S:1102 E:1104 ||| ,
69 ||| S:1104 E:1106 ||| CD
/ ||| S:1106 E:1107 ||| CD
150 ||| S:1107 E:1110 ||| CD
)  ||| S:1110 E:1112 ||| -RRB-
was  ||| S:1112 E:1116 ||| VBD
significangly  ||| S:1116 E:1130 ||| RB
higher  ||| S:1130 E:1137 ||| JJR
that  ||| S:1137 E:1142 ||| IN
in  ||| S:1142 E:1145 ||| IN
patients  ||| S:1145 E:1154 ||| NNS
with  ||| S:1154 E:1159 ||| IN
46 ||| S:1159 E:1161 ||| CD
,  ||| S:1161 E:1163 ||| ,
XX  ||| S:1163 E:1166 ||| NNP
( ||| S:1166 E:1167 ||| -LRB-
9.44 ||| S:1167 E:1171 ||| NNP
% ||| S:1171 E:1172 ||| NN
,  ||| S:1172 E:1174 ||| ,
17 ||| S:1174 E:1176 ||| CD
/ ||| S:1176 E:1177 ||| CD
180 ||| S:1177 E:1180 ||| CD
)  ||| S:1180 E:1182 ||| -RRB-
as  ||| S:1182 E:1185 ||| IN
well  ||| S:1185 E:1190 ||| RB
as  ||| S:1190 E:1193 ||| IN
46 ||| S:1193 E:1195 ||| CD
,  ||| S:1195 E:1197 ||| ,
XY  ||| S:1197 E:1200 ||| NNP
( ||| S:1200 E:1201 ||| -LRB-
6.67 ||| S:1201 E:1205 ||| NNP
% ||| S:1205 E:1206 ||| NN
,  ||| S:1206 E:1208 ||| ,
3 ||| S:1208 E:1209 ||| CD
/ ||| S:1209 E:1210 ||| CD
45 ||| S:1210 E:1212 ||| CD
;  ||| S:1212 E:1214 ||| :
Chi  ||| S:1214 E:1218 ||| NNP
square  ||| S:1218 E:1225 ||| NN
=  ||| S:1225 E:1227 ||| SYM
146.25 ||| S:1227 E:1233 ||| CD
,  ||| S:1233 E:1235 ||| ,
P=0.000 ||| S:1235 E:1242 ||| CD
) ||| S:1242 E:1243 ||| -RRB-
.  ||| S:1243 E:1245 ||| .
All  ||| S:1245 E:1249 ||| DT
primary  ||| S:1249 E:1257 ||| JJ
amenorrhea  ||| S:1257 E:1268 ||| JJ
patients  ||| S:1268 E:1277 ||| NNS
with  ||| S:1277 E:1282 ||| IN
deletion  ||| S:1282 E:1291 ||| NN
or  ||| S:1291 E:1294 ||| CC
break-point  ||| S:1294 E:1306 ||| JJ
at  ||| S:1306 E:1309 ||| IN
Xp1  ||| S:1309 E:1313 ||| NNP
1.1-11.4  ||| S:1313 E:1322 ||| NNP
were  ||| S:1322 E:1327 ||| VBD
short  ||| S:1327 E:1333 ||| JJ
statures ||| S:1333 E:1341 ||| NN
.  ||| S:1341 E:1343 ||| .
One  ||| S:1343 E:1347 ||| CD
of  ||| S:1347 E:1350 ||| IN
the  ||| S:1350 E:1354 ||| DT
main  ||| S:1354 E:1359 ||| JJ
reasons  ||| S:1359 E:1367 ||| NNS
of  ||| S:1367 E:1370 ||| IN
primary  ||| S:1370 E:1378 ||| JJ
amenorrhea  ||| S:1378 E:1389 ||| NN
is  ||| S:1389 E:1392 ||| VBZ
choromosome  ||| S:1392 E:1404 ||| JJ
abnormality ||| S:1404 E:1415 ||| NN
,  ||| S:1415 E:1417 ||| ,
especially  ||| S:1417 E:1428 ||| RB
heterosome  ||| S:1428 E:1439 ||| JJ
abnormality ||| S:1439 E:1450 ||| NN
.  ||| S:1450 E:1452 ||| .
It  ||| S:1452 E:1455 ||| PRP
implies  ||| S:1455 E:1463 ||| VBZ
the  ||| S:1463 E:1467 ||| DT
need  ||| S:1467 E:1472 ||| NN
to  ||| S:1472 E:1475 ||| TO
routinely  ||| S:1475 E:1485 ||| RB
screen  ||| S:1485 E:1492 ||| VB
chromosomal  ||| S:1492 E:1504 ||| JJ
anomalies  ||| S:1504 E:1514 ||| NN
for  ||| S:1514 E:1518 ||| IN
such  ||| S:1518 E:1523 ||| JJ
patients ||| S:1523 E:1531 ||| NNS
.  ||| S:1531 E:1533 ||| .
There  ||| S:1533 E:1539 ||| EX
might  ||| S:1539 E:1545 ||| MD
be  ||| S:1545 E:1548 ||| VB
relationship  ||| S:1548 E:1561 ||| NN
between  ||| S:1561 E:1569 ||| IN
Xp1  ||| S:1569 E:1573 ||| CD
1.1-11.4  ||| S:1573 E:1582 ||| CD
integrity  ||| S:1582 E:1592 ||| NN
and  ||| S:1592 E:1596 ||| CC
height  ||| S:1596 E:1603 ||| JJ
improvement ||| S:1603 E:1614 ||| NN
.  ||| S:1614 E:1616 ||| .
